Orchestra BioMed Holdings, Inc.

NASDAQ:OBIO

2.65 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020
Operating Activities:
Net Income -61.024-49.12-33.608-23.014-21.355
Depreciation & Amortization 0.3080.2870.2220.1810.137
Deferred Income Tax 00-3.6350.2880
Stock Based Compensation 10.6157.6253.4130.3020.221
Change In Working Capital -0.765-3.307-0.4512.597-8.12
Accounts Receivables 0.022-0.0030.0250.047-0.079
Inventory -0.0280.131-0.2080.001-0.026
Accounts Payables 2.9690.1450.1831.078-2.607
Other Working Capital -3.728-3.58-0.4511.471-5.408
Other Non Cash Items 0.308-1.6124.770.2172.934
Operating Cash Flow -50.558-46.127-29.289-19.429-26.183
Investing Activities:
Investments In Property Plant And Equipment -0.289-0.078-0.591-0.274-0.539
Acquisitions Net 00-29.06-13.291-27.505
Purchases Of Investments -72.648-142.032-63.531-0.213-15.624
Sales Maturities Of Investments 86.628152.79792.59113.50443.129
Other Investing Activites -0.6020-63.53113.29127.505
Investing Cash Flow 13.08910.687-64.12213.01726.966
Financing Activities:
Debt Repayment 15-10.8493.554-410
Common Stock Issued 15.0350.254109.830162.285
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities -0.86457.064-10.1270.0070
Financing Cash Flow 29.17146.215103.257-3.99310
Other Information:
Effect Of Forex Changes On Cash 0011.42500
Net Change In Cash -8.29810.77518.03-10.40510.783
Cash At End Of Period 22.26130.55919.7849.93820.343